FORTREA HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.39 USD | +4.83% |
|
-0.63% | -27.25% |
| May. 30 | Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research | CI |
| May. 29 | TD Cowen Starts Fortrea Holdings With Hold Rating, $27 Price Target | MT |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 3,099 | 2,269 | - | - |
| Enterprise Value (EV) 1 | 4,583 | 3,838 | 3,691 | 3,536 |
| P/E ratio | -873 x | -24.1 x | 42.1 x | 19.6 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 1 x | 0.81 x | 0.77 x | 0.73 x |
| EV / Revenue | 1.47 x | 1.37 x | 1.26 x | 1.14 x |
| EV / EBITDA | 17.1 x | 15.8 x | 10.4 x | 9.04 x |
| EV / FCF | 36.1 x | 53.5 x | 22.9 x | 16.3 x |
| FCF Yield | 2.77% | 1.87% | 4.36% | 6.13% |
| Price to Book | 1.78 x | 1.34 x | 1.21 x | 1.1 x |
| Nbr of stocks (in thousands) | 88,800 | 89,374 | - | - |
| Reference price 2 | 34.90 | 25.39 | 25.39 | 25.39 |
| Announcement Date | 3/11/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 3,109 | 2,799 | 2,930 | 3,095 |
| EBITDA 1 | - | 267.3 | 242.2 | 353.9 | 391.1 |
| EBIT 1 | - | 170.9 | 200.5 | 327 | 353.7 |
| Operating Margin | - | 5.5% | 7.16% | 11.16% | 11.43% |
| Earnings before Tax (EBT) 1 | 237 | 1.1 | -131 | 37.85 | 113.9 |
| Net income 1 | 192.9 | -3.4 | -116.1 | 51.53 | 92.11 |
| Net margin | - | -0.11% | -4.15% | 1.76% | 2.98% |
| EPS 2 | - | -0.0400 | -1.052 | 0.6025 | 1.293 |
| Free Cash Flow 1 | - | 127.1 | 71.8 | 161.1 | 216.6 |
| FCF margin | - | 4.09% | 2.57% | 5.5% | 7% |
| FCF Conversion (EBITDA) | - | 47.55% | 29.64% | 45.51% | 55.39% |
| FCF Conversion (Net income) | - | - | - | 312.57% | 235.18% |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 5/15/23 | 3/11/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 793 | 776.4 | 775.4 | 662.1 | 687.6 | 713.7 | 731.1 | 702.8 | 724.4 |
| EBITDA 1 | 72.5 | 70.5 | 67.2 | 29.5 | 52.29 | 72.42 | 88.05 | 64.49 | 82.06 |
| EBIT 1 | 63 | 45.9 | 43.3 | 7.6 | 37.64 | 55.56 | 78.16 | 52.55 | 77.17 |
| Operating Margin | 7.94% | 5.91% | 5.58% | 1.15% | 5.47% | 7.78% | 10.69% | 7.48% | 10.65% |
| Earnings before Tax (EBT) 1 | - | - | -41 | -77.5 | -32.97 | 1.875 | 20.56 | 5.017 | 20.53 |
| Net income 1 | 28.3 | -13.1 | -36 | -102.8 | -32.4 | -8.93 | 0.2029 | -6.678 | 8.06 |
| Net margin | 3.57% | -1.69% | -4.64% | -15.53% | -4.71% | -1.25% | 0.03% | -0.95% | 1.11% |
| EPS 2 | 0.3200 | -0.1500 | -0.4100 | -1.150 | -0.2533 | 0.006670 | 0.1167 | -0.0300 | 0.0950 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/14/23 | 11/13/23 | 3/11/24 | 5/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 1,483 | 1,569 | 1,422 | 1,267 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 5.55 x | 6.477 x | 4.017 x | 3.24 x |
| Free Cash Flow 1 | - | 127 | 71.8 | 161 | 217 |
| ROE (net income / shareholders' equity) | - | 4.9% | 3.92% | 8.54% | 8.47% |
| ROA (Net income/ Total Assets) | - | 2.88% | 1.07% | 2.68% | 4.02% |
| Assets 1 | - | -118 | -10,822 | 1,921 | 2,293 |
| Book Value Per Share 2 | - | 19.60 | 18.90 | 20.90 | 23.00 |
| Cash Flow per Share 2 | - | 1.970 | 0.5200 | 2.350 | 2.530 |
| Capex 1 | - | 40.3 | 57.8 | 47.1 | 56.7 |
| Capex / Sales | - | 1.3% | 2.06% | 1.61% | 1.83% |
| Announcement Date | 5/15/23 | 3/11/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
25.39
USD
Average target price
32.22
USD
Spread / Average Target
+26.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.25% | 2.27B | |
| +43.36% | 54.63B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B |
- Stock Market
- Equities
- FTRE Stock
- Financials Fortrea Holdings Inc.
